Skip to content

Study · Animal study (in vivo) · rat · 2023

8 results

Innate Vascular Failure by Application of Neuroleptics, Amphetamine, and Domperidone Rapidly Induced Severe Occlusion/Occlusion-like Syndromes in Rats and Stable Gastric Pentadecapeptide BPC 157 as Therapy.

Strbe S, Smoday IM, Krezic I, Kalogjera L, Vukovic V, Zizek H, Gojkovic S, Vranes H, Barisic I, Sikiric S, Tepes M, Oroz K and 9 more

Show all authors

Brkic F, Drinkovic M, Beketic Oreskovic L, Popic J, Boban Blagaic A, Skrtic A, Staresinic M, Seiwerth S, Sikiric P

Pharmaceuticals (Basel, Switzerland)25 May 2023Cited by 14 (Europe PMC)

Summary

Even before behavioral disturbances, neuroleptics, amphetamine, and domperidone application rapidly emerged severe occlusion/occlusion-like syndrome, shared innate vascular and multiorgan failure in rats, comparable to occlusion/occlusion-like syndrome described with vessel(s) occlusion or similar noxious procedures application. As therapy, i.e., activation of the collateral pathways, "bypassing key" (activated azygos vein pathway, direct blood flow delivery), the stable gastric pentadecapeptide BPC 157 is a novel solution. Recently, BPC 157 therapy particularly counteracted neuroleptic- or L-NAME-induced catalepsy, lithium intoxication, and schizophrenia positive and negative symptoms (amphetamine/methamphetamine/apomorphine/ketamine). In rats with complete calvariectomy, medication (BPC 157 10 µg/kg, 10 ng/kg ip or ig) was given 5 min after distinctive dopamine agents (mg/kg ip) (haloperidol (5), fluphenazine (5), clozapine (10), risperidone (5), olanzapine (10), quetiapine (10), or aripiprazole (10), domperidone (25), amphetamine (10), and combined amphetamine and haloperidol) and assessed at 15 min thereafter. All neuroleptic-, domperidone-, and amphetamine-induced comparable vascular and multiorgan failure severe syndrome was alleviated with BPC 157 therapy as before major vessel(s) occlusion or other similar noxious procedures. Specifically, all severe lesions in the brain (i.e., immediate swelling, hemorrhage), heart (i.e., congestion, arrhythmias), and lung (i.e., congestion, hemorrhage), as well as congestion in the liver, kidney, and gastrointestinal (stomach) tract, were resolved. Intracranial (superior sagittal sinus), portal, and caval hypertension and aortal hypotension were attenuated or eliminated. BPC 157 therapy almost annihilated arterial and venous thrombosis, peripherally and centrally. Thus, rapidly acting Virchow triad circumstances that occur as dopamine central/peripheral antagonists and agonist essential class-points, fully reversed by BPC 157 therapy, might be overwhelming for both neuroleptics and amphetamine.
CC BYText from Europe PMC. Highlighted sentences are the source of results.

Results from this study8

8 results from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In rats given neuroleptics, domperidone or amphetamine, BPC‑157 therapy alleviated the severe vascular and multiorgan failure syndrome that these drugs induced.

    In plain wordsIn rats given these drugs, BPC‑157 eased the severe blood vessel and organ damage that the drugs caused.

    Peptide
    BPC-157
    Outcome
    DecreaseVascular and multiorgan failure syndrome
    Study

    ratn: not reported in source

    Neuroleptic-, domperidone- or amphetamine-induced occlusion-like syndrome
    Outcome group
    Cardiovascular events · Cardiovascular
    Studied dose
    10 µg/kg and 10 ng/kg · intraperitoneal or intragastricAs given in this study (rat).

    Source sentences

    Summary
    All neuroleptic-, domperidone-, and amphetamine-induced comparable vascular and multiorgan failure severe syndrome was alleviated with BPC 157 therapy as before major vessel(s) occlusion or other similar noxious procedures.
    1 context sentence
    Summary · context
    In rats with complete calvariectomy, medication (BPC 157 10 µg/kg, 10 ng/kg ip or ig)
  2. 02AnimalAnimal study (in vivo)Efficacy outcome

    In rats given neuroleptics, domperidone or amphetamine, BPC‑157 therapy resolved severe brain lesions, including swelling and hemorrhage.

    In plain wordsIn rats given these drugs, BPC‑157 resolved brain swelling and bleeding caused by the drugs.

    Peptide
    BPC-157
    Outcome
    DecreaseBrain lesions (swelling, hemorrhage)
    Study

    ratn: not reported in source

    Neuroleptic-, domperidone- or amphetamine-induced occlusion-like syndrome
    Outcome group
    Neuroprotection · Nervous system and cognition
    Studied dose
    10 µg/kg and 10 ng/kg · intraperitoneal or intragastricAs given in this study (rat).

    Source sentences

    Summary
    all severe lesions in the brain (i.e., immediate swelling, hemorrhage), heart (i.e., congestion, arrhythmias), and lung (i.e., congestion, hemorrhage), as well as congestion in the liver, kidney, and gastrointestinal (stomach) tract, were resolved
    1 context sentence
    Summary · context
    In rats with complete calvariectomy, medication (BPC 157 10 µg/kg, 10 ng/kg ip or ig)
  3. 03AnimalAnimal study (in vivo)Efficacy outcome

    In rats given neuroleptics, domperidone or amphetamine, BPC‑157 therapy resolved severe heart lesions, including congestion and arrhythmias.

    In plain wordsIn rats given these drugs, BPC‑157 resolved heart congestion and rhythm problems caused by the drugs.

    Peptide
    BPC-157
    Outcome
    DecreaseHeart lesions (congestion, arrhythmias)
    Study

    ratn: not reported in source

    Neuroleptic-, domperidone- or amphetamine-induced occlusion-like syndrome
    Outcome group
    Heart function · Cardiovascular
    Studied dose
    10 µg/kg and 10 ng/kg · intraperitoneal or intragastricAs given in this study (rat).

    Source sentences

    Summary
    all severe lesions in the brain (i.e., immediate swelling, hemorrhage), heart (i.e., congestion, arrhythmias), and lung (i.e., congestion, hemorrhage), as well as congestion in the liver, kidney, and gastrointestinal (stomach) tract, were resolved
    1 context sentence
    Summary · context
    In rats with complete calvariectomy, medication (BPC 157 10 µg/kg, 10 ng/kg ip or ig)
  4. 04AnimalAnimal study (in vivo)Efficacy outcome

    In rats given neuroleptics, domperidone or amphetamine, BPC‑157 therapy resolved severe lung lesions, including congestion and hemorrhage.

    In plain wordsIn rats given these drugs, BPC‑157 resolved lung congestion and bleeding caused by the drugs.

    Peptide
    BPC-157
    Outcome
    DecreaseLung lesions (congestion, hemorrhage)
    Study

    ratn: not reported in source

    Neuroleptic-, domperidone- or amphetamine-induced occlusion-like syndrome
    Outcome group
    Cardiovascular events · Respiratory
    Studied dose
    10 µg/kg and 10 ng/kg · intraperitoneal or intragastricAs given in this study (rat).

    Source sentences

    Summary
    all severe lesions in the brain (i.e., immediate swelling, hemorrhage), heart (i.e., congestion, arrhythmias), and lung (i.e., congestion, hemorrhage), as well as congestion in the liver, kidney, and gastrointestinal (stomach) tract, were resolved
    1 context sentence
    Summary · context
    In rats with complete calvariectomy, medication (BPC 157 10 µg/kg, 10 ng/kg ip or ig)
  5. 05AnimalAnimal study (in vivo)Efficacy outcome

    In rats given neuroleptics, domperidone or amphetamine, BPC‑157 therapy resolved congestion in the liver, kidney and stomach.

    In plain wordsIn rats given these drugs, BPC‑157 resolved blood pooling in the liver, kidney and stomach caused by the drugs.

    Peptide
    BPC-157
    Outcome
    DecreaseLiver, kidney and gastrointestinal congestion
    Study

    ratn: not reported in source

    Neuroleptic-, domperidone- or amphetamine-induced occlusion-like syndrome
    Outcome group
    Cardiovascular events · Cardiovascular
    Studied dose
    10 µg/kg and 10 ng/kg · intraperitoneal or intragastricAs given in this study (rat).

    Source sentences

    Summary
    all severe lesions in the brain (i.e., immediate swelling, hemorrhage), heart (i.e., congestion, arrhythmias), and lung (i.e., congestion, hemorrhage), as well as congestion in the liver, kidney, and gastrointestinal (stomach) tract, were resolved
    1 context sentence
    Summary · context
    In rats with complete calvariectomy, medication (BPC 157 10 µg/kg, 10 ng/kg ip or ig)
  6. 06AnimalAnimal study (in vivo)Efficacy outcome

    In rats given neuroleptics, domperidone or amphetamine, BPC‑157 therapy attenuated or eliminated intracranial, portal and caval hypertension.

    In plain wordsIn rats given these drugs, BPC‑157 lowered or removed the high pressure in the brain, portal and caval veins.

    Peptide
    BPC-157
    Outcome
    DecreaseIntracranial, portal and caval hypertension
    Study

    ratn: not reported in source

    Neuroleptic-, domperidone- or amphetamine-induced occlusion-like syndrome
    Outcome group
    Blood pressure · Cardiovascular
    Studied dose
    10 µg/kg and 10 ng/kg · intraperitoneal or intragastricAs given in this study (rat).

    Source sentences

    Summary
    Intracranial (superior sagittal sinus), portal, and caval hypertension
    1 context sentence
    Summary · context
    In rats with complete calvariectomy, medication (BPC 157 10 µg/kg, 10 ng/kg ip or ig)
  7. 07AnimalAnimal study (in vivo)Efficacy outcome

    In rats given neuroleptics, domperidone or amphetamine, BPC‑157 therapy attenuated or eliminated aortal hypotension.

    In plain wordsIn rats given these drugs, BPC‑157 lessened or removed the low aortic blood pressure caused by the drugs.

    Peptide
    BPC-157
    Outcome
    IncreaseAortal hypotension
    Study

    ratn: not reported in source

    Neuroleptic-, domperidone- or amphetamine-induced occlusion-like syndrome
    Outcome group
    Blood pressure · Cardiovascular
    Studied dose
    10 µg/kg and 10 ng/kg · intraperitoneal or intragastricAs given in this study (rat).

    Source sentences

    Summary
    aortal hypotension were attenuated or eliminated.
    1 context sentence
    Summary · context
    In rats with complete calvariectomy, medication (BPC 157 10 µg/kg, 10 ng/kg ip or ig)
  8. 08AnimalAnimal study (in vivo)Efficacy outcome

    In rats given neuroleptics, domperidone or amphetamine, BPC‑157 therapy almost eliminated arterial and venous thrombosis, peripherally and centrally.

    In plain wordsIn rats given these drugs, BPC‑157 almost removed blood clots in arteries and veins.

    Peptide
    BPC-157
    Outcome
    DecreaseArterial and venous thrombosis
    Study

    ratn: not reported in source

    Neuroleptic-, domperidone- or amphetamine-induced occlusion-like syndrome
    Outcome group
    Cardiovascular events · Cardiovascular
    Studied dose
    10 µg/kg and 10 ng/kg · intraperitoneal or intragastricAs given in this study (rat).

    Source sentences

    Summary
    BPC 157 therapy almost annihilated arterial and venous thrombosis, peripherally and centrally.
    1 context sentence
    Summary · context
    In rats with complete calvariectomy, medication (BPC 157 10 µg/kg, 10 ng/kg ip or ig)

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    10 Oct 2026, 08:19 UTC

    Study results updated

  2. Version 2

    9 Oct 2026, 03:03 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 02:56 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.